| Literature DB >> 31949878 |
Xiaoning Zhang1,2, Yuwen Wang1, Rui Zhao1, Xianyun Hu3, Baoren Zhang4, Xin Lv5, Zhenglong Guo6, Zhiqiang Zhang7, Jinghua Yuan8, Xu Chu1, Fei Wang9, Guang Li1, Xin Geng10, Yang Liu11, Lei Sui12, Feng Wang1,13.
Abstract
Sleep deprivation is reported to cause oxidative stress and is hypothesized to induce subsequent aging-related diseases including chronic inflammation, Alzheimer's disease, and cardiovascular disease. However, how sleep deprivation contributes to the pathogenesis of sleep deficiency disorder remains incompletely defined. Accordingly, more effective treatment methods for sleep deficiency disorder are needed. Thus, to better understand the detailed mechanism of sleep deficiency disorder, a sleep deprivation mouse model was established by the multiple platform method in our study. The accumulation of free radicals and senescence-associated secretory phenotype (SASP) was observed in the sleep-deprived mice. Moreover, our mouse and human population-based study both demonstrated that telomere shortening and the formation of telomere-specific DNA damage are dramatically increased in individuals suffering from sleeplessness. To our surprise, the secretion of senescence-associated cytokines and telomere damage are greatly improved by folic acid supplementation in mice. Individuals with high serum baseline folic acid levels have increased resistance to telomere shortening, which is induced by insomnia. Thus, we conclude that folic acid supplementation could be used to effectively counteract sleep deprivation-induced telomere dysfunction and the associated aging phenotype, which may potentially improve the prognosis of sleeplessness disorder patients.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31949878 PMCID: PMC6948340 DOI: 10.1155/2019/4569614
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1Folic acid attenuates sleep deprivation-induced oxidative stress and SASP disorder. (a) Experimental design. A schematic diagram showing that mice were fed a long-term folic acid-supplemented diet for more than two months, and sleep deprivation was performed for 20 h/day (01:00 pm to 09:00 am the following day) for 7 days. (b) The folic acid concentration in serum before and after folic acid deficiency (or supplementation). (c) Reactive oxygen species (ROS) in the liver was assayed using DCFH-DA as a probe. (d) Antioxidative capacity in the liver was detected by the total SOD assay kit with WST-8. (e, f) Secretion of tumor necrosis factor-α (TNF-α) in the plasma, detected by ELISA, and the fold change (SD/WC) in the FAD or FAS groups. (g) Secretion of interleukin-6 (IL-6) in the plasma, detected by ELISA. (h–k) The abundance of p53 and p16INK4a in the plasma was detected by ELISA and the fold change (SD/WC) in the FAD or FAS groups. Data are presented as the mean ± SEM (N = 7 per group). ∗P < 0.05; ∗∗P < 0.01; and ∗∗∗P < 0.001.
Figure 2Folic acid restrains telomere shortening induced by sleep deprivation. (a) The telomere length of bone marrow cells was detected by quantitative fluorescence in situ hybridization (Q-FISH) and is shown as average fluorescence units (AFUs). Scale bars are 10 μm. (b) Scatter plot of telomere AFUs for more than 200 cells of all mice. (c) The histogram displays the distribution of relative telomere length as AFUs. Data are presented as the mean ± SEM (N = 7 per group). ∗∗∗P < 0.001.
Figure 3Folic acid ameliorates telomere dysfunction and rescues spermatozoa motility defects induced by sleep deprivation. (a) Telomere damage shown by the colocalization of the telomere signals and DNA damage marker γ-H2AX (TIFs). Scale bars are 10 μm. (b, c) Representative TIFs of telomere damage images of all groups and the fold change (SD/WC) in the FAD or FAS groups. (d) Percentage of motile sperm. (e) Percentage of the forward motile sperm. (f) Percentage of stagnant sperm. Data are presented as the mean ± SEM (N = 7 per group). ∗P < 0.05 and ∗∗P < 0.01.
Figure 4Transcriptome profile analysis. (a) Heat map of gene expression in WC+FAD, SD+FAD, and SD+FAS mice (N = 2 per group). (b) Volcano plot showing the transcript levels differentially expressed between SD+FAD and WC+FAD mice. (c) Volcano plot showing the transcript levels differentially expressed between SD+FAS and SD+FAD mice. (d) Top representative pathways of enriched DEGs in the SD+FAD vs. WC+FAD group. (e) Top representative pathways of enriched DEGs in the SD+FAS vs. SD+FAD group. (f) Relative expression of Cox6a1 detected by real-time PCR. (g) Relative expression of Cox8a detected by real-time PCR. Data are presented as the mean ± SEM (N = 7 per group). ∗P < 0.05; ∗∗P < 0.01; and ∗∗∗P < 0.001.
Figure 5Elongated leukocyte telomere length is associated with a high concentration level of plasma folic acid in humans. (a) The leukocyte telomere length of the participants divided into two groups according to the sleep score. (b) The leukocyte telomere length of the participants divided into four groups according to both sleep score and blood folate concentration. (c) A multiple regression analysis was performed for all the individuals. (d) The correlation between leukocyte telomere length and age. (e) The correlation between leukocyte telomere length and triglycerides. (f) The correlation between leukocyte telomere length and blood folate concentration. Data are presented as the mean ± SEM. ∗∗∗P < 0.001.